<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126863</url>
  </required_header>
  <id_info>
    <org_study_id>425/2019BO1</org_study_id>
    <nct_id>NCT04126863</nct_id>
  </id_info>
  <brief_title>Omphaloceles and Associated Malformations</brief_title>
  <official_title>Omphaloceles and Associated Malformations in Preterm and Term Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Major birth defects like omphalocele are diagnosed in 3-8% of all newborns in Germany each&#xD;
      year. Prevention and treatment quality of congenital malformations are key concerns for child&#xD;
      health. Poor long-term outcome is more likely in the presence of associated structural or&#xD;
      chromosomal abnormalities that occur in approximately 50-77% of these infants. Furthermore,&#xD;
      many newborns have respiratory failure and supposedly pulmonary hypertension - another reason&#xD;
      for increased mortality.&#xD;
&#xD;
      As part of the Surveillance Unit for Rare Pediatric Conditions in Germany (Erhebungseinheit&#xD;
      für seltene pädiatrische Erkrankungen in Deutschland), all neonatological departments receive&#xD;
      over two years monthly reporting cards to notify the study centre of cases, which will be&#xD;
      analysed based on anonymised questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An observational study using anonymized questionnaires, enrolled over two years (01/07/2019 -&#xD;
      30/06/2021) via the Surveillance Unit for Rare Pediatric Conditions in Germany (ESPED -&#xD;
      Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland). The nationwide&#xD;
      epidemiological data collection contents information about the incidence of omphalocele,&#xD;
      associated malformations and risk factors for the occurrence of omphalocele, especially for&#xD;
      pulmonary hypertension and its treatment.&#xD;
&#xD;
      We use the following inclusion criteria: preterm and term babies' ≤ 28 days of life.&#xD;
&#xD;
      The aim of our study is a reliable, population-related data acquisition about prevalence of&#xD;
      omphalocele, associated malformations and possible risk factors and characteristic early&#xD;
      warning symptoms regarding concomitant diseases. Thereby, in the future it will be possible&#xD;
      to develop prevention strategies für early detection and treatment of omphalocele and the&#xD;
      associated malformations/ diseases to improve outcome for these babies. A further aim is to&#xD;
      follow-up the thriving and the psychomotor development of these babies in the age of two&#xD;
      years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Number of patients with Omphalocele</measure>
    <time_frame>two years</time_frame>
    <description>Collection of data to calculate the prevalence of omphaloceles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with omphaloceles and associated malformations, especially pulmonary hypertension</measure>
    <time_frame>two years</time_frame>
    <description>Collection of data to calculate the prevalence of omphalocele associated malformations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Two-years outcome</measure>
    <time_frame>two years</time_frame>
    <description>Monitoring of weighting and thriving and of psychomotor development on the basis of a general developmental screening tool (ages &amp; stages questionnaire)</description>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Omphalocele</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm and term babies with omphalocele ≤ 28 days of life&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  preterm and term newborns ≤ 28 days&#xD;
&#xD;
          -  present omphalocele&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Poets, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University Childrens Hospital Tübingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kerstin Gründler, Dr.</last_name>
    <phone>07071-29-82621</phone>
    <email>Kerstin.Gruendler@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rangmar Goelz, Dr.</last_name>
    <phone>07071-29-82621</phone>
    <email>Rangmar.Goelz@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neonatology</name>
      <address>
        <city>Tübingen</city>
        <zip>72074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerstin Gründler, Dr.</last_name>
      <email>Kerstin.Gruendler@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 19, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Umbilical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

